|
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Summary
This study will compare the effectiveness of two FDA approved antibiotics used for the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA).
Description
Winthrop University Hospital Clinical Trials Center in conjunction with The Winthrop Internal Medicine Association is conducting a clinical research study for patients who have been hospitalized for a skin and skin structure infection. This research study will look at effectiveness of two antibiotics. During the study, eligible participants will receive study drug and all study procedures that are not part of the standard of care at no cost. Compensation may be provided for time and travel.
Inclusion/exclusion
Inclusion/Exclusion: To be eligible for the study, you must; ¥ Be at least 18 years of age ¥ Be hospitalized (for less than 24 hours)with a skin and skin structure infection of a complicated nature (major cutaneous absess or wound infection) that requires IV antibiotics treatment for 3 to 14 days of hospitalization management. ¥ Infection suspected or documented to be caused by MRSA
Principal Investigator
Nicholas Berbari, MD
Email
clinicaltrials@winthrop.org
Other Contact
For more information please call 516-663-9582
|
